Evaluation And Management Of Meniere�s Disease | 12387
Otolaryngology: Open Access
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Meniere�s disease is a debilitating condition characterized by vertigo, hearing loss, and tinnitus/aural fullness. It currently affects about
615,000 Americans and about 45,500 new cases are diagnosed each year. Traditional management of the disease consists of a low-
salt diet, the use of diuretics, to a variety of surgeries. The use of intratympanic gentamicin has gained popularity over the years as a major
modality of treatment for Meniere�s disease. We review our experience short and long term with intratympanic gentamicin for Meniere�s
disease. Although intratympanic gentamicin comes with the risk of hearing loss, it�s favored for it�s significant control of vertigo attacks and
because it is a relatively non-invasive procedure. Complete to substantial control (class A & B) was achieved in 82.50% of our patients, with
an overall decrease of hearing of 1.70 dB and an overall drop in word recognition score of only 0.58% (56.29 dB/61.41% baseline to 57.99
dB/60.83% at follow-up). This talk will focus on our experience and results with intratympanic gentamicin for the treatment of Meniere�s
disease. We will also focus on hearing loss in some cases.
Richard J. Wiet, M.D., F.A.C.S., is Professor of Clinical Otolaryngology and Neurosurgery at Northwestern University and Senior Partner, Ear Institute of Chicago, LLC. Wiet has been consistently listed in Chicago?s Magazine?s ?Top Doctors? for years. In 2011, Dr. Wiet was presented with the Professional Excellence Award from the Acoustic Neuroma Association. Dr. Wiet?s 30 years in the field of neurotology is reflected in a textbook he edited, released in February, 2006, entitled ?Ear Surgery-Minimizing Risks and Complications,? published by Thieme International.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals